$6.91
0.58% yesterday
Nasdaq, Apr 24, 10:00 pm CET
ISIN
CA35954B2066
Symbol
QNTM

FSD Pharma Inc Stock price

$6.91
+1.36 24.50% 1M
+1.22 21.44% 6M
+3.23 87.77% YTD
-22.94 76.85% 1Y
-55.48 88.93% 3Y
-206.94 96.77% 5Y
-1,119.29 99.39% 10Y
Nasdaq, Closing price Thu, Apr 24 2025
+0.04 0.58%
ISIN
CA35954B2066
Symbol
QNTM

Key metrics

Market capitalization $15.89m
Enterprise Value $7.61m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
P/B ratio (TTM) P/B ratio 1.38
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-15.86m
Free Cash Flow (TTM) Free Cash Flow $-6.74m
Cash position $8.06m
EPS (TTM) EPS $-14.47
P/S forward 1.08
EV/Sales forward 0.25
Short interest 8.53%
Show more

Is FSD Pharma Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,790 stocks worldwide.

FSD Pharma Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast FSD Pharma Inc:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast FSD Pharma Inc:

Buy
100%

Financial data from FSD Pharma Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
- -
-
100%
- Direct Costs 0.49 0.49
80% 80%
-
-0.49 -0.49
80% 80%
-
- Selling and Administrative Expenses 8.79 8.79
15% 15%
-
- Research and Development Expense 6.08 6.08
58% 58%
-
-15 -15
8% 8%
-
- Depreciation and Amortization 0.49 0.49
80% 80%
-
EBIT (Operating Income) EBIT -16 -16
17% 17%
-
Net Profit -14 -14
22% 22%
-

In millions USD.

Don't miss a Thing! We will send you all news about FSD Pharma Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

FSD Pharma Inc Stock News

Neutral
GlobeNewsWire
about 24 hours ago
TORONTO, April 24, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) “Quantum BioPharma” or the “Company”), today announced it will host a Business Update Conference Call on Tuesday, May 6, 2025 at 4:30 p.m.
Neutral
GlobeNewsWire
3 days ago
TORONTO, April 22, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), is pleased to announce the appointment of Kevin Malone as an advisor to the Board of Directors. Mr. Malone brings a vast wealth of successful stock trading experience, especially in manipulated companies, from his years of wealth management.
Neutral
GlobeNewsWire
11 days ago
Awards in favour of Quantum BioPharma Totalling $180,000 upheld and is now due Awards in favour of Quantum BioPharma Totalling $180,000 upheld and is now due
More FSD Pharma Inc News

Company Profile

FSD Pharma Inc., through its subsidiary, FV Pharma Inc., produces medical cannabis in Canada. The company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for various central nervous system disorders, including chronic pain, fibromyalgia, and irritable bowel syndrome. FSD Pharma Inc. has a strategic alliance agreement with SciCann Therapeutics Inc. for the production and distribution of cannabinoid-based, patent pending, and indication-specific products; and collaborative research and development agreement with Solarvest BioEnergy Inc. The company is headquartered in Cobourg, Canada.

Head office Canada
CEO Zeeshan Saeed
Employees 7
Founded 1994
Website www.quantumbiopharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today